Literature DB >> 31602197

Torpedo Maculopathy Associated with NEXMIF Mutation.

Tuğba Alarcon-Martinez1, Ayesha Khan2,3, Kenneth A Myers1,3.   

Abstract

Mutations in the neurite extension and migration factor (NEXMIF) gene are associated with X-linked intellectual disability. Thus far, all males reported with NEXMIF mutations have mild to profound intellectual disability with varying combinations of autistic features, poor or absent speech, epilepsy, facial dysmorphism, and strabismus. Affected females tend to have milder intellectual disability but severe, drug-resistant epilepsy. Here, we present a 32-month-old boy with a novel de novo frameshift NEXMIF pathogenic variant (p.Glu375ArgfsX21) who has mild motor delay, language delay, autistic features, and strabismus. In addition to these commonly described findings of NEXMIF mutations, his fundus exam revealed a very rare ophthalmologic abnormality, torpedo maculopathy. This finding has not previously been reported with NEXMIF mutation; however, on literature review, 7/15 males with NEXMIF mutations had other ophthalmologic abnormalities. This patient expands the phenotypic spectrum for males with NEXMIF mutations and suggests that NEXMIF may play an important role in ocular development.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Generalized epilepsy; NEXMIF; Torpedo maculopathy; X-linked intellectual disability

Year:  2019        PMID: 31602197      PMCID: PMC6738190          DOI: 10.1159/000498835

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  16 in total

1.  Delineation of the KIAA2022 mutation phenotype: two patients with X-linked intellectual disability and distinctive features.

Authors:  Yukiko Kuroda; Ikuko Ohashi; Takuya Naruto; Kazumi Ida; Yumi Enomoto; Toshiyuki Saito; Jun-Ichi Nagai; Takahito Wada; Kenji Kurosawa
Journal:  Am J Med Genet A       Date:  2015-04-21       Impact factor: 2.802

2.  A duplication of the whole KIAA2022 gene validates the gene role in the pathogenesis of intellectual disability and autism.

Authors:  A Charzewska; S Rzońca; M Janeczko; M Nawara; M Smyk; J Bal; D Hoffman-Zacharska
Journal:  Clin Genet       Date:  2014-11-13       Impact factor: 4.438

3.  KIAA2022-related disorders can cause Jeavons (eyelid myoclonia with absence) syndrome.

Authors:  Debopam Samanta; Erin Willis
Journal:  Acta Neurol Belg       Date:  2018-02-07       Impact factor: 2.396

Review 4.  Fragile X and X-linked intellectual disability: four decades of discovery.

Authors:  Herbert A Lubs; Roger E Stevenson; Charles E Schwartz
Journal:  Am J Hum Genet       Date:  2012-04-06       Impact factor: 11.025

5.  Torpedo maculopathy: disease spectrum and associated choroidal neovascularisation in a paediatric population.

Authors:  Katherine Shirley; Marie O'Neill; Rachel Gamble; Anne Ramsey; Eibhlin McLoone
Journal:  Eye (Lond)       Date:  2018-03-20       Impact factor: 3.775

6.  De novo loss of function mutations in KIAA2022 are associated with epilepsy and neurodevelopmental delay in females.

Authors:  R Webster; M T Cho; K Retterer; F Millan; C Nowak; J Douglas; A Ahmad; G V Raymond; M R Johnson; A Pujol; A Begtrup; D McKnight; O Devinsky; W K Chung
Journal:  Clin Genet       Date:  2016-09-29       Impact factor: 4.438

7.  Loss of function of KIAA2022 causes mild to severe intellectual disability with an autism spectrum disorder and impairs neurite outgrowth.

Authors:  Lionel Van Maldergem; Qingming Hou; Vera M Kalscheuer; Marlène Rio; Martine Doco-Fenzy; Ana Medeira; Arjan P M de Brouwer; Christelle Cabrol; Stefan A Haas; Pierre Cacciagli; Sébastien Moutton; Emilie Landais; Jacques Motte; Laurence Colleaux; Céline Bonnet; Laurent Villard; Juliette Dupont; Heng-Ye Man
Journal:  Hum Mol Genet       Date:  2013-04-24       Impact factor: 6.150

Review 8.  Clinical spectrum of KIAA2022 pathogenic variants in males: Case report of two boys with KIAA2022 pathogenic variants and review of the literature.

Authors:  Melissa Lorenzo; Irene Stolte-Dijkstra; Patrick van Rheenen; Ronald Garth Smith; Tom Scheers; Jagdeep S Walia
Journal:  Am J Med Genet A       Date:  2018-04-25       Impact factor: 2.802

9.  Next generation sequencing in nonsyndromic intellectual disability: from a negative molecular karyotype to a possible causative mutation detection.

Authors:  Emmanouil Athanasakis; Danilo Licastro; Flavio Faletra; Antonella Fabretto; Savina Dipresa; Diego Vozzi; Anna Morgan; Adamo P d'Adamo; Vanna Pecile; Xevi Biarnés; Paolo Gasparini
Journal:  Am J Med Genet A       Date:  2013-12-04       Impact factor: 2.802

10.  De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy.

Authors:  Iris M de Lange; Katherine L Helbig; Sarah Weckhuysen; Rikke S Møller; Milen Velinov; Natalia Dolzhanskaya; Eric Marsh; Ingo Helbig; Orrin Devinsky; Sha Tang; Heather C Mefford; Candace T Myers; Wim van Paesschen; Pasquale Striano; Koen van Gassen; Marjan van Kempen; Carolien G F de Kovel; Juliette Piard; Berge A Minassian; Marjan M Nezarati; André Pessoa; Aurelia Jacquette; Bridget Maher; Simona Balestrini; Sanjay Sisodiya; Marie Therese Abi Warde; Anne De St Martin; Jamel Chelly; Ruben van 't Slot; Lionel Van Maldergem; Eva H Brilstra; Bobby P C Koeleman
Journal:  J Med Genet       Date:  2016-06-29       Impact factor: 6.318

View more
  3 in total

1.  NEXMIF/KIDLIA Knock-out Mouse Demonstrates Autism-Like Behaviors, Memory Deficits, and Impairments in Synapse Formation and Function.

Authors:  James Gilbert; Margaret O'Connor; Sebastian Templet; Mahsa Moghaddam; Anaïs Di Via Ioschpe; Amanda Sinclair; Ling-Qiang Zhu; Weifeng Xu; Heng-Ye Man
Journal:  J Neurosci       Date:  2019-11-08       Impact factor: 6.167

2.  Clonazepam as an Effective Treatment for Epilepsy in a Female Patient with NEXMIF Mutation: Case Report.

Authors:  Masashi Ogasawara; Eiji Nakagawa; Eri Takeshita; Kohei Hamanaka; Satoko Miyatake; Naomichi Matsumoto; Masayuki Sasaki
Journal:  Mol Syndromol       Date:  2020-09-01

3.  Clinical evaluation of torpedo maculopathy in an infant population with additional genetic testing for NEXMIF mutation.

Authors:  Gokhan Celik; Murat Gunay; Asli Vural; Osman Kizilay; Yasemin Kendir Demirkol; Muhammet Kazim Erol
Journal:  Eye (Lond)       Date:  2021-07-29       Impact factor: 4.456

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.